Nautilus in the news – Is this Silicon Valley duo the future of biotech?

In this Endpoints News piece, Jason Mast does a deep-dive into Andreessen Horowitz’ decision to invest in the next generation of biotech. The article describes the major impacts many expect artificial intelligence and machine learning will have on researchers’ ability to engineer biology and make advancements in healthcare. Nautilus is highlighted as a company with “bilingual” founders who bridge computer science and biology to create innovative technologies. Discussing the promise of Nautilus’ technology to comprehensively quantify the proteome at scale and Nautilus co-founder Parag Mallick’s vision, Mast states:

Read the full article here.